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Abstract—This paper describes a novel micropositioning
mechanism for achieving 1ml of targeted drug delivery within
wireless capsule endoscopes. The mechanism allows a needle to
be positioned within a 22.5
o segment of a cylindrical capsule
and be extendible by up to 4mm. The mechanism achieves both
these functions using only a single micromotor and occupying a
volume of just 200mm
3 (including micromotor), this represents
only 6.6% of the total available space. Through a detailed
stress analysis it has been shown that the proposed mechanism
can be fabricated using FDA approved materials and requires
a power budget of under 3.3% of the available capacity. It
is envisaged this mechanism would empower a new breed
of capsule microrobots for therapy in addition to diagnostics
for pathologies such as ulcerative colitis and small intestinal
Crohn’s disease.
I. INTRODUCTION
The diagnosis and treatment of pathologies of the gas-
trointestinal (GI) tract are performed routinely by gastroen-
terologists using endoscopes and colonoscopes however the
small intestinal tract is out of the reach of these conventional
systems [1]. It is now commonplace for clinicians to access
inside the small intestines using wireless pill-sized cameras
which relay images of the intestinal wall for evaluation. This
practice enables the detection and diagnosis of pathologies of
the GI tract such as Crohn’s disease, small intestinal tumours
such as lymphoma and small intestinal cancer.
An early example of a basic pill-sized camera system
is the M2A. The M2A is a swallowable wireless capsule
endoscope (WCE) developed by Given Imaging Ltd. [2]
in 2000 to overcome the problem of examining the small
intestine. The capsule which is 11.0mm in diameter and
25.0mm long comprises a CMOS-based image sensor, four
LEDs for illumination, an RF module for communication
and an on-board power supply. Another similar system is
the EndoCapsule by Olympus [3], which uses a CCD-based
image sensor with 6 LEDs.
There is a clinical need to target and treat pathologies of
the GI tract such as ulcerative colitis, polyps and Crohn’s
disease [4]. Current systems are in general limited to diag-
nostic use and do not have the ability to deliver therapy to the
GI tract particularly within the conﬁned space of the small
intestine.
Resent measures have been taken to address this need
through the application of regional drug absorption services.
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Fig. 1. Microrobot concept design capable of delivering targeted therapy
to the gastrointestinal tract
The IntelliCap [5] by Philips Electronics, the InteliSite [6]
by Innovative Devices LLC and the Enterion capsule [7] by
Phaeton Research can all deliver medication to a region of
the GI tract by means of releasing up to 1ml of medication
which is stored onboard the capsule. The medication can be
expelled to a target region of the GI tract such as the jejunum,
ileum, ascending colon or descending colon.
Such systems are however unable to target speciﬁc
pathogens such as tumours or ulcers because they release
their payload progressively over a period of time or as a
bolus form. This has the effect of spreading the medication
over a section of lumen (due to peristalsis) as they have no
means of stopping or holding their position.
This paper presents a novel micropositioning system ca-
pable of targeting and treating pathologies of the GI tract.
Speciﬁcally this paper details the subminiature needle po-
sitioning and deployment mechanism (the stopping/holding
mechanism is not within the scope of this paper). The paper
is organised as follows: Section II describes the design
requirements, Section III describes the adopted concept and
Sections IV and V analyse the mechanics and conclude.
II. DESIGN REQUIREMENTS
The clinical need to target a speciﬁc location or feature
within the GI tract for medication delivery can be achieved
using a microrobot consisting of an onboard image sensor
and a drug targeting system (based on propelling the medi-
cation through a needle). Fig. 1 shows a concept design of
a microrobot with an integrated targeting system.
The proposed system would be more effective than current
systems due to the advantages of the shorter discharge time
and the more accurate delivery position. The shorter dis-
charge time will allow for the correct dosage to be deliveredto the required location without it being diluted over the
delivery time from the natural passing of the GI tract or from
being dispersed by the constant movement from peristalsis.
A. Design challenges
There are a number of design challenges that need to be
addressed to develop a working prototype capable of being
ingested. For example the limited capsule volume makes
integrating actuator mechanism and energy storage devices
particularly demanding:
1) Volume: Developing a targeting mechanism capable of
manoeuvring a needle requires the application of microac-
tuators however there are several limitations with current
microactuators which prevent a simple system integration.
Piezoelectric actuators require displacement ampliﬁcation
mechanisms to obtain a useful stroke length and also require
large drive voltages (100V) [8]. Micromotors could poten-
tially be used to drive mechanisms directly, however there
are very few commercially available which could ﬁt within
the package size of the capsule and have a useful torque
capability at a low RPM.
An alternative to micromotors as an actuator mechanism
are shape memory alloys (SMA) such as superelastic nitinol
which is an alloy of approximately 50% nickel and 50%
titanium. The superelastic properties of nitinol allow large
amounts of deformation to take place without permanently
damaging the lattice structure of the material. This allow-
able strain makes it possible to create super springs which
would be triggered by the Joules effect. The disadvantage
of SMAs is their relatively poor efﬁciency, therefore thermal
dissipation may lead to an elevated capsule temperature that
is highly undesirable [9].
2) Torque: A crucial feature of micromotors is their
ability to deliver a useful torque. It is possible to estimate
the torque required to operate the targeting mechanism by
using dimensions based on the M2A and applying equation
T = mk2. The radius of gyration (k) would be 5.5mm,
the angular acceleration () can be derived from the motor’s
performance, also by approximating the volume of steel the
micromotor would be required to move, the mass (m) of the
steel can be found by rearranging equation  = kg=m3.
The results of the initial torque analysis, which are based
on using a 1.5mm diameter  10.5mm long micromotor
manufactured by Namiki (no. 10-010) show that a torque
of 3.22Nm would be required to operate the targeting
mechanism. This ﬁgure is well within the 1.6mNm available
from the Namiki motor however provision will need to be
made for the inherent friction in the mechanism and for any
load which would be generated by the needle positioning
mechanism itself.
3) Energy requirement: One of the fundamental limita-
tions of microactuators is power consumption as space to
store energy is limited. Silver oxide button cell batteries
are a standard method of powering WCEs with energy
density ratios as high as 500Wh=L (watt hours per litre)
however their median operating voltage is between 1.2 to
1.5V requiring at least two cells to directly power a 3.0V
micromotor.
Lithium Manganese Dioxide (Li/MnO2) batteries offer
higher voltage ranges at 2.5 to 3.0V with higher energy
density ratios which can be as high as 550Wh=L however
they require a larger volume of space than lithium-ion
polymer batteries (LiPo). LiPo batteries offer similar energy
density ratios as lithium-ion batteries however their main
advantage is their form factor.
B. Target technical speciﬁcation
The size and shape of the microrobotic system are depen-
dent on the limitations imposed by swallowing and on the
microrobot’s ability to navigate the ileocolic valve without
becoming an obstruction. Determining the overall geometry
presents a potential problem as the maximum volume a
patient can swallow will vary greatly from person to person.
A volume of 3.0cm3 has been chosen as the maximum
boundary for swallowing as recent research (Connor et al.
2009) has shown this to be achievable [10]. The target vol-
ume will be required to house all the components necessary
to perform targeted therapy and microscale diagnosis. Table
I lists the overall technical requirements for the microrobot
platform.
TABLE I
OVERALL MICROROBOT TECHNICAL REQUIREMENTS
Requirement Speciﬁcation
Microrobot volume maximum 3.0cm3
Sensing pH, temp and pressure
Vision CMOS and optical dome
Illumination 4 white LEDs
Power source onboard supply
Tracking RF and time
Telemetry bidirectional
Delivering therapy liquid medication
Drug reservoir 1ml
III. DESIGN CONCEPT
The needle positioning mechanism (Fig. 2) utilises a
single micromotor to position and operate the needle. The
design of the needle positioning mechanism consists of a
1.5mm diameter  10.5mm long micromotor manufactured
by Namiki, two opposing ratchets, a needle funnel, a needle
cam and a movable needle. Also features integral to the
microrobot’s body are required. The ﬁrst operation is the
angular control of the position of the needle and the second
is the extension and retraction of the needle. The medication
will be stored in a compartment of the body and be delivered
through the needle by means of pressure generated by a
piston. The piston will be activated by a spring allowing
for a rapid delivery of the medication.
It is a requirement that the needle can be positioned at
selected points within a 360 degree envelope. For the purpose
of prototyping 16 ﬁxed positions equally spaced have been
chosen. The angular positioning of the needle is achievedRatchet
Protrusions
Needle
Case
Needle cam
Fig. 2. Needle positioning mechanism assembly with material removed
for clarity. Needle shown in the partially extended position
by the anticlockwise rotation of the micromotor while the
advancement and retraction of the needle is achieved by the
clockwise rotation of the micromotor.
A. Positioning the needle
Manoeuvring the needle to a selected position is achieved
by applying a negative voltage to the micromotor. The
negative voltage will cause the micromotor to rotate in an
anticlockwise direction. The needle funnel (Fig. 3a) rotates
anticlockwise by virtue of a ratchet which is mounted on the
micromotor’s driveshaft. The ratchet engages with a set of
sprung legs which are integral to the needle funnel (Fig. 3b).
The needle is engaged with the needle funnel and is carried
round with it.
Fig. 3. Needle positioning mechanism extended cantilever: needle funnel
a), ratchet driving the needle funnel b) and the needle funnel arm engaged
with a protrusion c)
When the needle funnel is rotating anticlockwise an arm
which protrudes from the side of the needle funnel rides
over the top of a plurality of protrusions (Fig. 3b) on the
inside face of the body. The function of these protrusions is
to prevent the needle funnel from rotating clockwise when
the motor is reversed. It achieves this by engaging the end
of the arms with a parallel surface of the protrusion (Fig. 3c)
preventing any further movement clockwise and aligning the
needle with one of the 16 ﬁxed ports on the microrobot’s
body.
B. Operating the needle
Applying a positive voltage to the micromotor reverses its
direction, this disengages the needle funnel ratchet from its
sprung legs and engages the needle cam ratchet with a set
of sprung legs that are integral to the needle cam (Fig. 4a).
When engaged the ratchet drives the needle cam in a
clockwise direction. The needle is engaged with a track in the
Fig. 4. 360 degree needle cam operating cycle: stored position a), full
stroke b), needle returning to the stored position c), and retracted position
d)
needle cam by means of a driving peg mounted on the side
of the needle. The track is shaped to convert the rotational
motion of the cam into a variable linear motion. This linear
motion allows the advancement and retraction of the needle.
Fig. 4 shows the sequence of operation for the extension
and retraction of the needle. Fig. 4a shows the needle in
the stored position, this is the position the needle will be in
when the microrobot will be swallowed and travel through
the GI tract to the target site. Fig. 4b shows the needle
at full extension giving a reach of approximately 8.85mm
radius and a stroke length of 4.0mm. The design of the cam
utilises a direct linear movement so that a positive force can
be delivered to the needle which will be required to penetrate
the wall of the GI tract. Fig. 4c shows the needle retracting
backwards by virtue of the track slowly spiralling inwards.
Fig. 4d shows the needle returning to the stored position once
the medication has been delivered.
IV. DESIGN ANALYSIS
When the needle funnel (Fig. 3a) rotates anticlockwise the
arm on the side is required to ﬂex out of position as it rides
over the protrusions on the body (Fig. 3c). This ﬂexing out
of position will result in a stress induced in the arm. The
amount of stress in the arm will be a result of the material’s
geometry, the Young’s modulus for the material and the
amount of movement the arm will make. Various materials
can be evaluated for their ability to withstand this stress and
continue to function correctly. To determine the most suitable
for this application Table II shows a selection of materials
and their properties which can be compared for the purpose
of evaluating the needle positioning arm (Fig. 3a).
Using the principle of a cantilevered beam the displace-
ment of the beam can be calculated by using  = PL3=3EI.
As the distance the arm will be ﬂexed through is known ()
and the material’s Young’s modulus E, the second moment
of area of the beam I and the length of the arm L are also
known the equation can be rearranged to ﬁnd the load (P)TABLE II
MATERIAL SELECTION MATRIX
Material Density Yield Shear Young’s Poisson’s
g=cm3 point modulus modulus ratio
N=mm2 kN=mm2 kN=mm2
Stainless Steel 304 8.08 290 72.4 193 0.3
Ti Alloy 6AL 4V 4.43 880 42.7 114 0.3
Nylon 6 1.14 82 1.24 3.3 0.4
PVC 1.44 58 1.13 3.0 0.4
Acetal Copolymer 1.41 60 1.01 2.7 0.4
PEEK 450G 1.32 97 1.31 3.5 0.4
that would be required to make the displacement. The applied
load can be used to determine the stress induced in the arm.
A. Needle funnel arm simulation
For a structure to be considered stable in operation the
maximum stress induced in the structure must be below the
limiting property factor of strength for the material, this limit
is known as the yield point of the material and it is the point
where permanent deformation of the material occurs. Using
the geometry of the needle funnel arm and a point load (P) of
12.55mN derived from a 0.17mm displacement of a PEEK
needle funnel arm a ﬁnite element analysis (FEA) has been
performed, Fig. 5.
Fig. 5. Von Mises FEA 2D isoareas and displacement analysis of a PEEK
needle funnel arm with a point load of 12.55mN
The FEA analysis (Fig. 5) shows the maximum Von Mises
stress to be 15.47N=mm2 from an applied load of 12.55mN
at the end of the arm, also a stress of 3.86N=mm2 can
be seen running through the beam as a contour of light
brown indicated by arrow (A). The analysis shows that
the maximum predicted stress is 6.25 times lower than the
97N=mm2 yield point of PEEK, this gives an acceptable
margin for safety to accommodate for any variations in
material and geometry. The displacement analysis, arrow (B),
shows the movement of the arm. The resulting stress in the
arm is of a magnitude which would allow the arm to recover
back to its original starting position when the applied load
is removed. This will allow the needle funnel to lock into
position when it is rotated clockwise.
B. Energy requirements
It is an important requirement that the needle positioning
mechanism can operate with low power consumption and
as such the FEA ﬁndings have been used to reduce the
micromotor’s operating load. It has been calculated using a
battery volume of 188mm3 and a Lithium Manganese Diox-
ide battery that a complete cycle of the needle positioning
mechanism will consume at most 12.16J of the available
energy. This is based on the peak power consumption of
a 1.5mm diameter  10.5mm long four stage geared mi-
cromotor manufactured by Namiki (no. 10-010) operating
for approximately 2.5 seconds. This represents only 3.3%
of the available energy, offering the potential for multiple
repositions.
V. CONCLUSION
In this paper we have presented a novel mechanism
towards the realisation of a practical micropositioning system
for targeted drug delivery in the small intestines. The system
can be used for the detection and treatment of pathologies of
the GI tract such as Crohn’s disease, small intestinal tumours
such as lymphoma and small intestinal cancer.
It has been shown that the proposed needle positioning
system achieves the required functionality whilst occupying
a volume of only 200mm3. This is based on a single
micromotor and is estimated to consume a maximum of
12.16J of energy per activation.
In order to achieve the control necessary to target a
particular pathogen within the GI tract the microrobot would
be required to hold itself in position, resisting the natural
movement from peristalsis. It is envisaged that a stopping
mechanism capable of resisting peristalsis can be incorpo-
rated into the standard geometry of the WCE, with the com-
bined needle positioning system and stopping mechanism
occupying 13% of the total available volume.
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